References

Abdel-Meguid T. Botulinum toxin-A injections into neurogenic overactive bladder—to include or exclude the trigone? A prospective, randomized, controlled trial. J urology 2010;184(6):2423-2428.

Abdill CK, Rivas DR, Chancellor MB. Transurethral placement of external sphincter wire mesh stent for neurogenic bladder. SCI Nurs 1994;11(2):38-41.

Abdul-Rahman A, Ismail S, Hamid R, Shah J. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU International 2010; 106: 1510-1513.

Abrams P, Amarenco G, Bakke A, Buczynski A, Castro-Diaz D, Harrison S et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol 2003;170(4 Pt 1):1242-1251.

Adler US, Kirshblum SC. A new assistive device for intermittent self-catheterization in men with tetraplegia. J Spinal Cord Med 2003;26:155-8.

Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ et al. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int 2007;100(3):639-645.

Akkoç Y, Ersöz M, Yıldız N, Erhan B, Alaca R, Gök H, Uygunol K. Effects of different bladder management methods on the quality of life in patients with traumatic spinal cord injury. Spinal Cord 2013;51(3):226-231.

Al-Ali M, Salman G, Rasheed A, Al-Ani G, Al-Rubaiy S, Alwan A et al. Phenoxybenzamine in the management of neuropathic bladder following spinal cord injury. Aust N Z J Surg 1999;69(9):660-663.

Alvares R, Silva,J, Barboza A, Monteiro R. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity. International braz j urol 2010;36(6):732-737.

Amend B, Hennenlotter J, Schafer T. Horstmann M. Stenzyl A. Sievert K.D. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. European Urology 2008;53:1021-1028.

Anderson TP, Newman E, Dryja R, Price M. Urinary tract care: Improvement through patient education. Arch Phys Med Rehabil 1983;64(7):314-316.

Afsar SI, Yemisci OU, Cosar SN, Cetin N. Compiance with clean intermittent catheterization in spinal cord injury patients: A long-term follow-up study. Spinal Cord 2013;51(8), 645-649.

Bagi P, Biering-Sørensen F. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scandinavian J Urol and nephrology 2004;38(6):495-498.

Barber DB, Woodard FL, Rogers SJ, Able AC. The efficacy of nursing education as an intervention in the treatment of recurrent urinary tract infections in individuals with spinal cord injury. SCI Nurs 1999;16(2):54-56.

Bennett CJ, Young MN, Razi SS, Admins R, Diaz F, McCrary A. The effect of urethral introducer tip catheters on the incidence of urinary tract infection outcomes in spinal cord injured patients. J Urol. 1997 Aug;158(2):519-21.

Bermingham SL, Hodgkinson S, Wright S, Hayter E, Spinks J, Pellowe C. Intermittent self-catheterization with hyrophillic, gel reservoir, and non-coated catheters: A systematic review and cost effectiveness analysis. BMJ 2013;346:e8639.

Bersch U, Gocking K, Pannek J. The artificial urinary sphincter in patients with spinal cord lesion: Description of a modified technique and clinical results. European Urology 2009;55:687-695.

Biering-Sorensen F, Bagi P, Hoiby N. Urinary tract infections in patients with spinal cord lesions: Treatment and prevention. Drugs 2001;61(9):1275-1287.

Biering-Sorensen F, Hansen HV, Nielsen PN, Looms D. Residual urine after intermittent catheterization in females using two different catheters. Scand J Urol Nephrol 2007;41:341-345.

Biering-Sorensen F, Hoiby N, Nordenbo A, Ravnborg M, Bruun B, Rahm V. Ciprofloxacin as prophylaxis for urinary tract infection: Prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol 1994;151(1):105-108.

Biering-Sorensen F. Urinary tract infection in individuals with spinal cord lesion. Curr Opin Urol 2002;12(1):45-49. Böthig R, Fiebag K, Thietje R, Faschingbauer M, Hirschfeld S. Morbidity of urinary tract infection after urodynamic examination of hospitalized SCI patients: The impact of bladder management. Spinal Cord 2013;51(1):70-73.

Böthig R, Hirschfeld S, Thietje R. Quality of life and urological morbidity in tetraplegics with artificial ventilation managed with suprapubic or intermittent catheterisation. Spinal Cord 2012;50(3):247-251.

Brindley GS, Polkey CE, Rushton DN. Sacral anterior root stimulators for bladder control in paraplegia. Paraplegia 1982;20(6):365-381.

Bycroft JA, Craggs MD, Sheriff M, Knight S, Shah PJ. Does magnetic stimulation of sacral nerve roots cause contraction or suppression of the bladder? Neurourol Urodyn 2004;23(3):241-245.

Cardenas DD, Hoffman JM, Kelly E, Mayo ME. Impact of a urinary tract infection educational program in persons with spinal cord injury. J Spinal Cord Med 2004;27(1):47-54.

Cardenas DD, Hoffman JM. Hydrophilic catheters versus noncoated catheters for reducing the incidence of urinary tract infections: A randomized controlled trial. Arch Phys Med Rehabil 2009;90:1668-1671.

Cardenas DD, Moore KN, Dannels-McClure A, Scelza WM, Graves DE, Brooks M et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: A prospective, randomized, multicenter trial. PM R 2011;3:408-417.

Caremel R, Courtois F, Charvier K, Ruffion A, Journel N. Side effects of intradetrusor botulinum toxin injections on ejaculation and fertility in men with spinal cord injury: Preliminary findings. BJU international 2012;109(11):1698-1702.

Castello T, Girona L, Gomez MR, Mena MA, Garcia L. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord 1996;34(10):592-593.

Chancellor MB, Bennett C, Simoneau AR, Finocchiaro MV, Kline C, Bennett JK et al. Sphincteric stent versus external sphincterotomy in spinal cord injured men: Prospective randomized multicenter trial. J Urol 1999;161(6):1893-1898.

Chancellor MB, Erhard MJ, Rivas DA. Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function. J Am Paraplegia Soc 1993a;16(4):207-214.

Chancellor MB, Karasick S, Strup S, Abdill CK, Hirsch IH, Staas WE. Transurethral balloon dilation of the external urinary sphincter: Effectiveness in spinal cord-injured men with detrusor-external urethral sphincter dyssynergia. Radiology 1993b;187(2):557-560.

Chancellor MB, Karusick S, Erhard MJ, Abdill CK, Liu JB, Goldberg BB, Staas WE. Placement of a wire mesh prosthesis in the external urinary sphincter of men with spinal cord injuries. Radiology 1993c;187(2):551-555.

Chancellor MB, Rivas DA, Abdill CK, Staas WE, Jr., Bennett CJ, Finocchiaro MV et al. Management of sphincter dyssynergia using the sphincter stent prosthesis in chronically catheterized SCI men. J Spinal Cord Med 1995;18(2):88-94.

Chancellor MB, Rivas DA, Staas WE, Jr. DDAVP in the urological management of the difficult neurogenic bladder in spinal cord injury: Preliminary report. J Am Paraplegia Soc 1994b;17(4):165-167. Charbonneau-Smith R. No-touch catheterization and infection rates in a select spinal cord injured population. Rehabil Nurs 1993;18(5):296-9, 305.

Charlifue SW, Weitzenkamp DA, Whiteneck GG. Longitudinal outcomes in spinal cord injury: Aging, secondary conditions, and well-being. Arch Phys Med Rehabil 1999;80(11):1429-1434.

Chartier-Kastler E, Amarenco G, Lindbo L, Soljanik I, Andersen HL, Bagi P, Gjodsbol K, Domurath B. A prospective, randomized, crossover, multicenter study comparing quality of life using compact versus standard catheter for intermittent self-catheterization. J Urol 2013;190:942-947.

Chartier-Kastler E, Azouvi P, Yakovleff A, Bussel B, Richard F, Denys P. Intrathecal catheter with subcutaneous port for clonidine test bolus injection. A new route and type of treatment for detrusor hyperreflexia in spinal cord-injured patients. Eur Urol 2000a;37(1):14-17.

Chartier-Kastler EJ, Genevois S, Game X, Denys P, Richard F, Leriche A et al. Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: A French retrospective multicentre study. BJU International 2011;107:426-432.

Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO, Chancellor MB, Richard F, Denys P. Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 2000b;38(8):490-494.

Chartier-Kastler EJ, Mozer P, Denys P, Bitker MO, Haertig A, Richard F. Neurogenic bladder management and cutaneous non-continent ileal conduit. Spinal Cord 2002;40(9):443-448.

Chen C, Liao C, Kuo H. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Spinal Cord 2011;49(5):659-664.

Chen G, Liao L. Injections of botulinum toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury. Intern Urol Nephrol 2011;43(3):655-662.

Chen JL, Kuo HC. Long-term outcomes of augmentation enteroplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc 2009;108(6):475-480.

Chen S, Kuo H. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. Journal of the Formosan Medical Association 2013.

Chen SL, Bih LI, Chen GD, Huang YH, You YH, Lew HL. Transrectal ultrasound-guided transperineal botulinum toxin A injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. Arch Phys Med Rehabil 2010;91:340-344.

Chen SL, Bih LI, Huang YH, Tsai SJ, Lin TB, Kao YL. Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury. J Rehabil Med 2008;40(9):744-748.

Cheng P-T, Wong M-K, Chang P-L. A therapeutic trial of acupuncture in neurogenic bladder of spinal cord injured patients-A preliminary report. Spinal Cord 1998;36(7):476-480.

Colli J, Lloyd K. Bladder neck closure and suprapubic catheter placement as definitive management of neurogenic bladder. J Spinal Cord Med 2011;34(3):273-277.

Cook JB, Smith PH. Percutaneous suprapubic cystostomy after spinal cord injury. Br J Urol 1976;48(2):119-121.

Costa JA, Menier M, Doran TJ, Kohler TS. Catheter length preference in wheelchair-using men who perform routine clean intermittent catheterization. Spinal Cord 2013;51(10):772-775.

Costa P, Bressolle F, Sarrazin B, Mosser J, Sabatier R. Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries. Clin Pharm Therap 1993;53(4):443-449.

Craven ML, Etchells J. A review of the outcome of stoma surgery on spinal cord injured patients. J Adv Nurs 1998;27(5):922-926.

Creasey GH, Grill JH, Korsten M, HS U, Betz R, Anderson R et al. An implantable neuroprosthesis for restoring bladder and bowel control to patients with spinal cord injuries: A multicenter trial. Arch Phys Med Rehabil 2001;82(11):1512-1519.

Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial. Euro Urol 2011;60(4):742-750.

Dalmose AL, Rijkhoff NJ, Kirkeby HJ, Nohr M, Sinkjaer T, Djurhuus JC. Conditional stimulation of the dorsal penile/clitoral nerve may increase cystometric capacity in patients with spinal cord injury. Neurourol Urodyn 2003;22(2):130-137.

Darouiche RO, Goetz L, Kaldis T, Cerra-Stewart C, AlSharif A, Priebe M. Impact of StatLock securing device on symptomatic catheter-related urinary tract infection: A prospective, randomized, multicenter clinical trial. Am J Infect Control 2006;34(9):555-560.

Darouiche RO, Green BG, Donovan WH, Chen D, Schwartz M, Merritt J, et al. Multiceter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 2011;78(2):341-346.

Darouiche RO, Priebe M, Clarridge JE. Limited vs full microbiological investigation for the management of symptomatic polymicrobial urinary tract infection in adult spinal cord-injured patients. Spinal Cord 1997;35(8):534-539.

Darouiche RO, Smith MS, Markowski J. Antibiotic prophylaxis for urodynamic testing in patients with spinal cord injury: A preliminary study. J Hosp Infect 1994;28(1):57-61.

Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. Bacterial interference for prevention of urinary tract infection: A prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005;41(10):1531-1534.

Das A, Chancellor MB, Watanabe T, Sedor J, Rivas DA. Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia. J Spinal Cord Med 1996;19(3):190-193.

Dasgupta P, Chandiramani V, Parkinson MC, Beckett A, Fowler CJ. Treating the human bladder with capsaicin: Is it safe? Eur Urol 1998;33(1):28-31.

De Groat WC. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Paraplegia 1995;33(9):493-505

De Laet K, Wyndaele J. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005;43(7):397-399.

De Ridder DJ, Everaert K, Fernandez LG, Valero JV, Duran AB, Abrisqueta ML et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: A prospective randomised parallel comparative trial. Eur Urol 2005;48(6):991-995.

Dedeic-Ljubovic A, Hukic M. Catheter-related urinary tract infection in patients suffering from spinal cord injuries. Bosn J Basic Med Sci 2009;9(1):2-9.

Del Popolo G, Filocamo M, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol 2008;53(5):1013-1019.

Denys P, Prévinaire JG, Aegerter P, de Sèze M, Karsenty G, Amarenco G. Intermittent self-catheterization habits and opinion on aspetic VaPro catheter in French neurogenic bladder population. Spinal Cord 2012;50(11):853-858.

DeSeze M, Petit H, Gallien P, de Seze MP, Joseph PA, Mazaux JM et al. Botulinum a toxin and detrusor sphincter dyssynergia: A double-blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol 2002;42(1):56-62.

DeSeze M, Wiart L, de Seze MP, Soyeur L, Dosque JP, Blajezewski S et al. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: A double-blind, randomized, controlled study. J Urol 2004;171(1):251-255.

DeSeze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M. Capsaicin and neurogenic detrusor hyperreflexia: A double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998;17(5):513-523.

DeVivo, M.J. Sir Ludwig Guttman Lecture: Trends in SCI rehabilitation outcomes from model systems in the United States:1973-2006. Spinal Cord 2007;45(11):713-721.

Domurath B, Kutzenberger JM, Kurze I, Knoth HS. Clinical evaluation of a newly developed catheter (SpeediCath Compact Male) in men with spinal cord injury: Residual urine and user evaluation. Spinal Cord 2011;49:817-821.

Dow G, Rao P, Harding G, Brunka J, Kennedy J, Alfa M et al. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 2004;39(5):658-664.

Drake MJ, Cortina-Borja M, Savic G, Charlifue SW, Gardner BP. Prospective evaluation of urological effects of aging in chronic spinal cord injury by method of bladder management. Neurourol Urodyn 2005;24(2):111-116.

Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol 1992;44(4):611-615.

Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139(5):919-922.

Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: A double-blind study. Arch Phys Med Rehabil 1990;71(1):24-26.

Egon G, Barat M, Colombel P, Visentin C, Isambert JL, Guerin J. Implantation of anterior sacral root stimulators combined with posterior sacral rhizotomy in spinal injury patients. World J Urol 1998;16(5):342-349.

Ehren I, Volz D, Farrelly E, Berglund L, Brundin L, Hultling C et al. Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: A randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 2007;41(4):335-340.

El-Masri WS, Chong T, Kyriakider AE, Wang D. Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of The Midlands Centre for Spinal Injuries in Oswestry. Spinal cord 2012;50(1):14-21.

Ersoz M, Yildiz N, Akyuz M, Koseoglu F. Efficacy of combined oral-intravesical oxybutynin hydrochloride treatment for patients with overactive detrusors and indwelling urethral catheters. Rehabil Nurs 2010;35(2):80-86.

Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000;164(4):1285-1289.

Ethans KD, Nance PW, Bard RJ, Casey AR, Schryvers OI. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med 2004;27(3):214-218.

Evans RJ. Intravesical therapy for overactive bladder. Current Urology Reports 2005;6:429-433.

Faarvang KL, Muller P, Lomberg B, Biering-Sorensen F. Screening for bacteriuria in patients with spinal cord lesion: Dipstick test, microscopic examination and urine culture. Spinal Cord 2000;38(2):106-108.

Farag FF, Martens FM, Rijkhoff NJ, Heesakkers JP. Dorsal genital nerve stimulation in patients with detrusor overactivity: A systematic review. Curr Urol Rep 2012;12(5):385-388.

Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis Mon;49(2):53-70.

Gacci M, Del Popolo G, Macchiarella A, Celso M, Vittori G, Lapini A, et al. Vardenafil improves urodynamic parameters in men with spinal cord injury: Results from a single dose, pilot study. J urology 2007;178(5):2040-2044.

Gallien P, Nicolas B, Robineau S, Le Bot MP, Durufle A, Brissot R. Influence of urinary management on urologic complications in a cohort of spinal cord injury patients. Arch Phys Med Rehabil 1998;79(10):1206-1209.

Game X, Chartier-Kastler E, Ayoub N, Even-Schneider A, Richard F, Denys P. Outcome after treatment of detrusor-sphincter dyssynergia by temporary stent. Spinal Cord 2008;46:74-77.

Garcia Leoni ME, Esclarin De RA. Management of urinary tract infection in patients with spinal cord injuries. Clin Microbiol Infect 2003;9(8):780-785.

George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. Scientific World Journal 2007;7:1683-1690.

Giannantoni A, Di Stasi SM, Scivoletto G, Virgili G, Dolci S, Porena M. Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study. J Urol 2001;166(1):130-133.

Giannantoni A, Meatini E, Del Zingaro M, Porena M. Six-year follow-up of Botulinum Toxin A intradetrosrial injections in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results. European Urology 2009;55:705-712.

Giannantoni A, Scivoletto G, Di Stasi SM, Silecchia A, Finazzi-Agro E, Micali I et al. Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. Spinal Cord 1998;36(1):29-32.

Gilmore DS, Schick DG, Young MN, Montgomerie JZ. Effect of external urinary collection system on colonization and urinary tract infections with Pseudomonas and Klebsiella in men with spinal cord injury. J Am Paraplegia Soc 1992;15(3):155-157.

Ginsberg D, Gousse A, Keppenne V, Sievert K, Thompson C, Lam W et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J urology 2012;187(6):2131-2139.

Gobeaux N, Yates DR, Denys P, Even‐Schneider A, Richard F, Chartier‐Kastler E. Supratrigonal cystectomy with hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: Long‐term functional results. Neurourology and urodynamics 2012;31(5):672-676.

Goetz LL, Cardenas DD, Kennelly M, Bonne Lee BS, Linsenmeyer T Moser C, Pannek J et al.International Spinal Cord Injury Urinary Tract Infection Basic Data Set. Spinal Cord 2013;51(9):700-704.

Gohbara A, Tanaka K, Kawaji K, Yokomizo Y. Urinary tract management in patients with incomplete cervical cord injury during the recovery phase. Spinal cord 2013;51(4):310-313.

Goldman HB, Amundsen CL, Mangel J, Grill J, Bennet M, Gustafson KJ, Grill WM. Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms. Neurourol Urodyn 2008;27(6):499-503.

Green BG. Changes in bladder management of spinal cord-injured patients through the years: Have we succeeded in keeping our patients catheter-free. Top Spinal Cord Injury Rehabilitation 2004;10(2):79-85.

Greenstein A, Rucker KS, Katz PG. Voiding by increased abdominal pressure in male spinal cord injury patients–long term follow up. Paraplegia 1992;30(4):253-255.

Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: A prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med 1993;95(2):141-152.

Grijalva I, Garcia-Perez A, Diaz J, Aguilar S, Mino D, Santiago-Rodriguez E, et al. High doses of 4-aminopyridine improve functionality in chronic complete spinal cord injury patients with MRI evidence of cord continuity. Arch Med Res 2010;41:567-575.

Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 2002;83(3):346-351.

Grosse J, Kramer G, Jakse G. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: A case-control study. BJU International 2009;104:651-656.

Gu YD. New progress in diagnosis and treatment of brachial plexus injury. Linchuang Waike Zazhi 2005;13:30-32.

Gurung PM, Attar KH, Abdul-Rahman A, Morris T, Hamid R, Shah PJ. Long-term outcomes of augmentation ileocystoplasty inpatients with spinal cord injury: A minimum of 10 years of follow-up. BJU Int 2012;109(8):1236-1242.

Gurung P, Attar KH, Abdul‐Rahman A, Morris T, Hamid R, Shah PJR. Long‐term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: A minimum of 10 years of follow‐up. BJU international 2012;109(8):1236-1242.

Hackler RH. Long-term Suprapubic cystostomy drainage in spinal cord injury patients. Br J Urol 1982;54(2):120-121.

Haferkamp A, Schurch B, Reitz A, Krengel U, Grosse J, Kramer G. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. European urology 2004;46(6):784-791.

Haferkamp A, Staehler G, Gerner HJ, Dörsam J. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 2000;38(4):250-254.

Hagglund KJ, Clark MJ, Schopp LH et al. Consumer-assistant education can reduce the occurrence of urinary tract infections among persons with spinal cord injury. Top in Spinal Cord Rehabil 2005;10(5):53-62.

Hajebrahimi S, Altaweel W, Cadoret J, Cohen E, Corcos J. Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: Initial results. Canadian J Urol 2005;12:2543-2546.

Hakenberg OW, Ebermayer J, Manseck A, Wirth MP. Application of the Mitrofanoff principle for intermittent self-catheterization in quadriplegic patients. Urology 2001;58(1):38-42.

Hull R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C, Darouiche R. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 2000;163(3):872-877.

Hamid R, Khastqir J, Arya M, Patel HR, Shah PJ. Experience of tension-free vaginal tape for the treatment of stress incontinence in females with neuropathic bladders. Spinal Cord 2003;41(2):118-121.

Hanno PM, Sant GR. Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology 2001;57(6 Suppl 1):2-6.

Hansen J, Media S, Nohr M, Biering-Sorensen F, Sinkjaer T, Rijkhoff NJ. Treatment of neurogenic detrusor overactivity in spinal cord injured patients by conditional electrical stimulation. J Urol 2005;173(6):2035-2039.

Hansen RB, Biering-Sorensen F, Kristensen JK. Urinary calculi following traumatic spinal cord injury. Scandinavian J Urol Nephrol 2007;41:115-9.

Hassouna M, Elmayergi N, Abdelhady M. Update on sacral neuromodulation: Indications and outcomes. Curr Urol Rep 2003 Oct;4(5):391-398.

Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G et al. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: A randomized, double-blind trial. J urology 2011;185(6):2229-2235.

Hess MJ, Hess PE, Sullivan MR, Nee M, Yalla SV. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008;46:622-626.

Hikita K, Honda M, Kawamoto B, Panagiota T, Inoue S, Hinata N. Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients. International J Urol 2013;20(1):94-99.

Hobson DA, Tooms RE. Seated lumbar/pelvic alignment. A comparison between spinal cord-injured and non-injured groups. Spine 1992;17(3):293-298.

Hoffman JM, Wadhwani R, Kelly E, Dixit B, Cardenas DD. Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J Spinal Cord Med 2004;27(2):128-132.

Hogel F et al. Functional outcome of patients 12 and 48 weeks after acute traumatic tetraplegia and paraplegia: Data analysis from 2004-2009. Spinal Cord 2012;50(7):517-520.

Hohenfellner M, Humke J, Hampel C, Dahms S, Matzel K, Roth S, Thuroff JW, Schultz-Lampel D. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: Long-term results with unilateral implants. Urology 2001;58(6):887-892.

Hori S, Patki P, Attar K, Ismail S, Vasconcelos J, Shah P. Patients’ perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury. BJU International 2009;104,:216-220.

Horstmann M, Schaefer T, Aguilar Y, Stenzl A, Sievert KD. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn 2006;25(5):441-445.

Horton JA, III, Kirshblum SC, Linsenmeyer TA, Johnston M, Rustagi A. Does refrigeration of urine alter culture results in hospitalized patients with neurogenic bladders? J Spinal Cord Med 1998;21(4):342-347.

Horvath EE, Yoo PB, Amundsen CL, Webster GD, Grill WM. Conditional and continuous electrical stiulation increase cystometric capacity in persons with spinal cord injury. Neurourol Urodyn 2010;29(3): 401-407.

Jensen AE, Hjeltnes N, Berstad J, Stanghelle JK. Residual urine following intermittent catheterisation in patients with spinal cord injuries. Paraplegia 1995;33(12):693-696.

Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;(1):CD001321.

Jia C, Liao LM, Chen G, Sui Y. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 2013;51(6):487-490.

Johansen TB, Hultling C, Madersbacher H, Del Popolo G, Amarenco G. A novel product for intermittent catheterisation: Its impact on compliance with daily life- international multicentre study. European Urology 2—7;52:213-220. Joshi A, Darouiche RO. Regression of pyuria during the treatment of symptomatic urinary tract infection in patients with spinal cord injury. Spinal Cord 1996;34(12):742-744.

Juma S, Mostafavi M, Joseph A. Sphincterotomy: Long-term complications and warning signs. Neurourol Urodyn 1995;14(1):33-41

Karsenty G, Chartier-Kastler E, Mozer P, Even-Schneider A, Denys P, Richard F. A novel technique to achieve cutaneous continent urinary diversion in spinal cord-injured patients unable to catheterize through native urethra. Spinal Cord 2008;46(4):305-310.

Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 2006;68(6):1193-1197.

Kato H, Hosaka K, Kobayashi S, Igawa Y, Nishizawa O. Fate of tetraplegic patients managed by ileal conduit for urinary control: Long-term follow-up. Int J Urol 2002;9(5):253-256.

Katsumi HK, Kalisvaart JF, Ronningen LD, Hovey Rm. Urethral versus suprapubic catheter: Choosing the best bladder management for male spinal cord injury patients with indwelling catheters. Spinal Cord 2010;48(4):325-329.

Katz PG, Greenstein A, Severs SL, Zampieri TA, Singh SK. Effect of implanted epidural stimulator on lower urinary tract function in spinal-cord-injured patients. Eur Urol 1991;20(2):103-106.

Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977;118(6):967-971.

Ke QS, Kuo HC. Transurethral incision of the bladder neck to treat bladder neck dysfunction and voiding dysfunction in patients with high-level spinal cord injuries. Neurourology and Urodynamics 2010;29:748-752.

Kennelly MJ, Lemack GE, Foote JE, Trop CS. Efficacy and safety of Oxybutynin Transdermal System in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: An open-label, dose-titration study. Urology 2009;74:741–745.

Khastgir J, Hamid R, Arya M, Shah N, Shah PJ. Surgical and patient reported outcomes of ‘clam’ augmentation ileocystoplasty in spinal cord injured patients. Eur Urol 2003;43(3):263-269.

Kim JH, Rivas DA, Shenot PJ, Green B, Kennelly M, Erickson JR et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: A multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 2003;26(4):358-363.

Kirkham AP, Knight SL, Craggs MD, Casey AT, Shah PJ. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord 2002;40(6):272-281.

Kirkham APS, Shah NC, Knight SL, Shah PJR, Craggs MD. The acute effects of continuous and conditional neuromodulation on the bladder in spinal cord injury. Spinal Cord 2001;39(8):420-428.

Klaphajone J, Kitisomprayoonkul W, Sriplakit S. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 2005;86:2114-2118.

Kovindha A, Mai WN, Madersbacher H. Reused silicone catheter for clean intermittent catheterization (CIC): Is it safe for spinal cord-injured (SCI) men? Spinal Cord 2004;42(11):638-642.

Krebs J, Pannek J. Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion. Spinal cord 2013;51(4):306-309.

Krebs M, Halvorsen RB, Fishman IJ, Santos-Mendoza N. Prevention of urinary tract infection during intermittent catheterization. Journal d’urologie 1984;131(1):82-85.

Krhut J, Samal V, Nemec D, Zvara P. Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: A pilot study. Spinal cord 2012;50(12):904-907.

Ku JH, Choi WJ, Lee KY et al. Complications of the upper urinary tract in patients with spinal cord injury: A long-term follow-up study. Urological Research 2005;33:435-9.

Ku JH, Jung TY, Lee JK, Park WH, Shim HB. Risk factors for urinary stone formation in men with spinal cord injury: A 17-year follow-up study. BJU Int 2006;97(4):790-793.

Kuo H. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion. Neurourol Urodyn 2008;27:793-796.

Kuo H. Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 2006;67:232-236.

Kuo H. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia. Inter J Clin Prac 2013;67(10):1044-1049.

Kutzenberger J, Domurath B, Sauerwein D. Spastic bladder and spinal cord injury: Seventeen years of experience with sacral deafferentation and implantation of an anterior root stimulator. Artif Organs 2005;29(3):239-241.

Kutzenberger J. Surgical therapy of neurogenic detrusor overactivity (hyperreflexia) in paraplegic patients by sacral deafferentation and implant driven micturition by sacral anterior root stimulation: Methods, indications, results, complications, and future prospects. Acta Neurochir Suppl 2007;97(1):333-339.

Lavado EL, Cardoso JR, Silva LG, ela Bela LF, Atallah AN. Effectiveness of aerobic physical training for treatment of chronic asymptomatic bacteriuria in subjects with spinal cord injury: A randomized controlled trial. Clin Rehabil 2013;27(2):142-149.

Lazzeri M, Calo G, Spinelli M, Guerrini R, Salvadori S, Beneforti P et al. Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: A randomized, placebo-controlled, double-blind study. Urology 2003;61(5):946-950.

Lazzeri M, Calò G, Spinelli M, Malaguti S, Guerrini R, Salvadori S et al. Daily intravesical instillation of 1 mg Nociceptin/Orphanin FQ for the control of neurogenic detrusor overactivity: A multicenter, placebo controlled, randomized exploratory study. J. Urol. 2006;176:2098-2102.

Lazzeri M, Spinelli M, Beneforti, P, Zanollo A, Turini D. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scandinavian J Urol and nephrology 1998;32(5):331-334.

Lecci A, Giuliani S, Meini S, Maggi CA. Nociceptin and the micturition reflex. Peptides 2000;21(7):1007-1021. Lee BB, Haran MJ, Hunt LM, Simpson JM, Marial O, Rutkowski SB et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord 2007;45(8):542-550.

Lee YH, Lee IS, Lee JY. Percutaneous electrical stimulation of sensory nerve fibers to iprove motor function: Application in voiding dysfunction. Cur Applied Physics 2005;5:542-545.

Lee YH, Kim JM, Im HT, Lee KW, Kim SH, Hur DM. Semiconditional electrical stimulation of pudendal nerve afferents stimulation to manage neurogenic detrusor overactivity in patients with spinal cord injury. Ann Rehabil Med 2011;35(5):605-612.

Lee YH, Kim SH, Kim JM, Im HT, Choi IS, Lee KW. The effect of semiconditional dorsal penile nerve electrical stimulation on capacity and compliance of the bladder deformity in spinal cord injury patients: A pilot study. Spinal Cord 2012;50(4):289-293.

Li L, Ye W, Ruan H, Yang B, Zhang S, Li L. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: Systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil 2013;94(4):782-787.

Lin H, Hou C. Transfer of normal S1 nerve root to reinnervate atonic bladder due to conus medullaris injury. Muscle Nerve 2013;47(2):241-245.

Lin H, Hou CL, Zhong G, Xie Q, Wang S. Reconstruction of reflex pathways to the atonic bladder after conus medullaris injury: Preliminary clinical results. Microsurgery 2008;28:429-435.

Lin H, Hou C, Zhen X, Xu Z. Clinical study of reconstructed bladder innervation below the level of spinal cord injury to produce urination by Achilles tendon-to-bladder reflex contractions. Journal of Neurosurgery Spine 2009;10:452-457.

Linsenmeyer TA, Harrison B, Oakley A, Kirshblum S, Stock JA, Millis SR. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med 2004;27(1):29-34.

Linsenmeyer TA, Horton J, Benevento J. Impact of alpha1-blockers in men with spinal cord injury and upper tract stasis. J Spinal Cord Med 2002;25(2):124-128.

Linsenmeyer TA, Jain A, Thompson BW. Effectiveness of neomycin/polymyxin bladder irrigation to treat resistant urinary pathogens in those with spinal cord injury. J Spinal Cord Med 1999;22(4):252-257.

Linsenmeyer TA, Oakley A. Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J Spinal Cord Med 2003;26(4):352-357.

Livshits A, Catz A, Folman Y, Witz M, Livshits V, Baskov A et al. Reinnervation of the neurogenic bladder in the late period of the spinal cord trauma. Spinal Cord 2004;42(4):211-217.

Lloyd LK, Kuhlemeier KV, Fine PR, Stover SL. Initial bladder management in spinal cord injury: Does it make a difference? Journal d’urologie 1986;135(3):523-527.

Locke JR, Hill DE, Walzer Y. Incidence of squamous cell carcinoma in patients with long-term catheter drainage. J Urol 1985;133(6):1034-1035.

Lombardi G, Del PG. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord 2009;47:486-491.

MacDiarmid SA, Arnold EP, Palmer NB, Anthony A. Management of spinal cord injured patients by indwelling suprapubic catheterization. J Urol 1995;154(2 I):492-494.

Madersbacher H, Pauer W, Reiner E. Rehabilitation of micturition by transurethral electrostimulation of the bladder in patients with incomplete spinal cord lesions. Paraplegia 1982;20(4):191-195.

Madersbacher H, Stöhrer M, Richter R, Burgdörfer H, Hachen H, Mürtz G. Trospium chloride versus oxybutynin: A randomized, double‐blind, multicentre trial in the treatment of detrusor hyper‐reflexia. British J Urol 1995;75(4):452-456.

Martens FMJ, den Hollander PP, Snoek GJ, Koldewijn EL, van Kerrebroeck PEVA, Heesakkers JPFA. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourology and Urodynamics 2011;30:551-555.

Martins CF, Bronzatto E, Neto JM, Magalhaes GS, D’anconna CA, Cliquet A Jr. Urinary tract infection analysis in a spinal cord inured population undergoing rehabilitation-how to treat? Spinal Cord 2013;51(3):193-195.

Mascarenhas F, Cocuzza M, Gomes C, Leão N. Trigonal injection of botulinum toxin‐A does not cause vesicoureteral reflux in neurogenic patients. Neurourol Urodyn 2008;27(4):311-314.

Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of runairy tract infection signs and symptoms in individuals with spinla cord injury on intermittent catheterization. J Spinal Cord Med 2009;32(5):568-573.

Mays R, McIntyre A, Mehta S, Hill D, Wolfe D, Teasell R. A review of educational programs to reduce UTIs among individuals with SCI. Rehabil Nurs 2014;39(5\0:240-249.

Mehta S, Hill D, McIntyre A, Foley N, Hsieh J, Ethans K et al. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Arch Phys Med Rehabil 2013;94(8):1473-1481.

Mehta SS, Tophill PR. Memokath stents for the treatment of detrusor sphincter dyssynergia (DSD) in men with spinal cord injury: The Princess Royal Spinal Injuries Unit 10-year experience. Spinal Cord 2006;44(1):1-6.

Meunier JC, Mollereau C, Toll L et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995;377(6549):532-535.

Moore KN, Burt J, Voaklander DC. Intermittent catheterization in the rehabilitation setting: A comparison of clean and sterile technique. Clin Rehabil 2006;20(6):461-468.

Morton SC Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002;83(10):129-138.

Nanninga JB, Wu Y, Hamilton B. Long-term intermittent catheterization in the spinal cord injury patient. J Urol 1982;128(4):760-763.

Newman E, Price M. External catheters: Hazards and benefits of their use by men with spinal cord lesions. Arch Phys Med Rehabil 1985;66(5):310-313. Nicita G. Neurogenic detrusor overactivity treated with English botulinum toxin A:8-year experience of one single centre. European urology 2008;53(5):1013-1020.

Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40(5):643-654.

Nomura S, Ishido T, Tanaka K, Komiya A. Augmentation ileocystoplasty in patients with neurogenic bladder due to spinal cord injury or spina bifida. Spinal Cord 2002;40(1):30-33.

Nwadiaro HC, Nnamonu MI, Ramyil VM, Igun GO. Comparative analysis of urethral catheterization versus suprapubic cystostomy in management of neurogenic bladder in spinal injured patients. Niger J Med 2007;16(4):318-321.

Oh SJ, Ku JH, Jeon HG, SHIN HI, Paik NJ, Yoo T. Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spincal cord injury. Urology 2005;65(2):306-10.

O’Leary M, Erickson JR, Smith CP, McDermott C, Horton J, Chancellor MB. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury. J Spinal Cord Med 2003;26(2):159-162.

Opisso E, Borau A, Rijkhoff NJ. Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor over activity at home. Neurourol Urodyn 2013;32(7):1004-1009.

Opisso E, Borau A, Rodriguez A, Hansen J, Rijkhoff NJ. Patient controlled versus automatic stimulation of pudendal nerve afferents to treat neurogenic detrusor overactivity. J Urol 2008;180(4):1403-1408.

Ord J, Lunn D, Reynard J. Bladder management and risk of bladder stone formation in spinal cord injured patients. Journal d’urologie 2003;170(5):1734-1737.

Pan D, Troy A, Rogerson J, Bolton D, Brown D, Lawrentschuk N. Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 2009;181:705-709.

Pannek J, Kullik B. Equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology 2009b;74:263-266.

Pannek J, Bartel P, Gocking K. Clinical usefulness of the transobturator sub-urethral tape in the treatment of stress urinary incontinence in female patients with spinal cord lesion. J Spinal Cord Med 2012;35(2):102-106.

Pannek J, Gocking K, Bersch U. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction. BJU International 2009a;104:1246-1250.

Pannek J, Nehiba M. Morbidity of urodynamic testing in patients with spinal cord injury: Is antibiotic prophylaxis necessary? Spinal Cord 2007;45(12):771-774.

Pannek J, Sommerfeld HJ, Bötel U, Senge T. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Urology 2000;55(3):358-362.

Patki P, Hamid R, Shah PJ, Craggs M. Long-term efficacy of AMS 800 artificial urinary sphincter in male patients with urodynamic stress incontinence due to spinal cord lesion. Spinal Cord 2006;44(5):297-300.

Pazooki D, Edlund C, Karlsson AK, Dahlstrand C, Lindholm E, Tornqvist H et al. Continent cutaneous urinary diversion in patients with spinal cord injury. Spinal Cord 2006;44(1):19-23.

Pearman JW, Bailey M, Riley LP. Bladder instillations of trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma.

Pearman JW, Bailey M, Harper WE. Comparison of the efficacy of “Trisdine” and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol 1988;62(2):140-144.

Pearman JW. The value of kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol 1979;51(5):367-374.

Peatfield RC, Burt AA, Smith PH. Suprapubic catheterisation after spinal cord injury: A follow-up report. Paraplegia 1983;21(4):220-226.

Perkash I, Kabalin JN, Lennon S, Wolfe V. Use of penile prostheses to maintain external condom catheter drainage in spinal cord injury patients. Paraplegia 1992;30(5):327-332.

Perkash I. Efficacy and safety of terazosin to improve voiding in spinal cord injury patients. J Spinal Cord Med 1995;18(4):236-239.

Perkash I. Transurethral sphincterotomy provides significant relief in autonomic dysreflexia in spinal cord injured male patients: Long-term followup results. J Urol, 2007;177(3):1026-1029.

Perrigot M, Delauche-Cavallier MC, Amarenco G, Geffriaud C, Stalla‐Bourdillon A, Costa P, et al. Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunction.Neurourology and urodynamics 1996;15(2):119-131.

Perrouin-Verbe B, Labat JJ, Richard I, Mauduyt de lG I, Buzelin JM, Mathe JF. Clean intermittent catheterization from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia 1995;33(11):619-624.

Petersen T, Nielsen J, Schrøder H. Intravesical capsaicin in patients with detrusor hyper-reflexia: A placebo-controlled cross-over study. Scandinavian J Urol and nephrology 1999;33(2):104-110.

Peterson AC, Curtis LH, Shea AM, Borawski KM, Schulman KA, Scales CD Jr. Urinary diversion in patients with spinal cord injury in the United States. Urology 2012;80(6):1247-1251.

Petit H, Wiart L, Gaujard E, Le BF, Ferriere JM, Lagueny A et al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998;36(2):91-94.

Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001;165(4):1107-1110.

Pickett G.E. et al. Epidemiology of traumatic SCI in Canada. Spine 2006;31(7):799-805.

Polliack T, Bluvshtein V, Philo O, Ronen J, Gelernter I, Luttwak ZP et al. Clinical and economic consequences of volume- or time-dependent intermittent catheterization in patients with spinal cord lesions and neuropathic bladder. Spinal Cord 2005;43(10):615-619.

Possover, M. The sacral LION procedure for recovery of bladder/rectum/sexual functions in paraplegic patients after explantation of a previous Finetech-Brindley controller. Journal of Minimally Invasive Gynecology 2009,16:98-101.

Prasad A, Cevallos ME, Riosa S, Darouiche RO, Trautner BW. A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord 2009, 47, 565-569.

Prasad KVR, Vaidyanathan S. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity. British J Urol 1993;72(5):719-722.

Previnaire JG, Soler JM, Perrigot M, Boileau G, Delahaye H, Schumacker P, Vanvelcenaher J, Vanhee JL. Short-term effect of pudendal nerve electrical stimulation on detrusor hyperreflexia in spinal cord injury patients: Importance of current strength. Paraplegia 1996;34(2):95-9.

Previnaire JG, Soler JM, Perrigot M. Is there a place for pudendal nerve maximal electrical stimulation for the treatment of detrusor hyperreflexia in spinal cord injury patients? Spinal Cord 1998;36(2):100-103.

Prieto-Fingerhut T, Banovac K, Lynne CM. A study comparing sterile and nonsterile urethral catheterization in patients with spinal cord injury. Rehabil Nurs 1997;22(6):299-302.

Quek ML, Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol 2003;169(1):195-198.

Radzieszewski K. Outcomes of electrical stimulation of the neurogenic bladder: Results of a two-year follow-up study. NeuroRehabilitation 2013;32(4):867-873.

Radziszewski K, Zielinski H, Radziszewski P, Swiecicki, R. Transcutaneous electrical stimulation of urinary bladder in patients with spinal cord injuries. Inter Urol Neph 2009, 41, 497-503.

Reid G, Dafoe L, Delaney G, Lacerte M, Valvano M, Hayes KC. Use of adhesion counts to help predict symptomatic infection and the ability of fluoroquinolones to penetrate bacterial biofilms on the bladder cells of spinal cord injured patients. Paraplegia 1994a;32(7):468-472.

Reid G, Hsieh J, Potter P, Mighton J, Lam D, Warren D et al. Cranberry juice consumption may reduce biofilms on uroepithelial cells: Pilot study in spinal cord injured patients. Spinal Cord 2001;39(1):26-30.

Reid G, Potter P, Delaney G, Hsieh J, Nicosia S, Hayes K. Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Agents 2000;13(4):305-307.

Reid G, Sharma S, Advikolanu K, Tieszer C, Martin RA, Bruce AW. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters. Antimicrob Agents Chemother 1994b;38(7):1490-1495.

Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 1995;270:792–794.

Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Euro Urol 2007;52(6):1729-1735.

Reitz A, Stohrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J et al. European experience of 200 cases treated with Botulinum-A Toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. European Urology 2004;45:510-515.

Reitz A, Knapp PA, Müntener M, Schurch B. Oral nitric oxide donors: A new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients? European Urology 2004;45(4):516-520.

Reyblat P, Chan KG, Josephson DY, Stein JP, Freeman JP, Grossfeld GD, Esrig D, Ginsberg DA. Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients. World J Urol. 2009;27:63-68.

Rivas DA, Chancellor MB, Bagley D. Prospective comparison of external sphincter prosthesis placement and external sphincterotomy in men with spinal cord injury. J Endourol 1994;8(2):89-93.

Robinson LQ, Grant A, Weston P, Stephenson TP, Lucas M, Thomas DG. Experience with the Brindley anterior sacral root stimulator. Br J Urol 1988;62(6):553-557.

Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gaillard JL et al. Prevention of urinary tract infection in spinal cord-injured patients: Safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up–an observational prospective study. J Antimicrob Chemother 2006;57(4):784-788.

Salomon J, Schnitzler A, Ville Y, Laffont I, Perronne C, Denys P, Bernard L. Prevention of urinary tract infection in six spinal cord-injured pregnant women who gave birth to seven children under a weekly oral cyclic antibiotic program. Inter J Infect Dis 2009;13:399-402.

Sanders PM, Ijzerman MJ, Roach MJ, Gustafson KJ. Patient preferences for next generation neural prostheses to restore bladder. Spinal Cord 2011;49(1):113-119.

Sanderson PJ, Weissler S. A comparison of the effect of chlorhexidine antisepsis, soap and antibiotics on bacteriuria, perineal colonization and environmental contamination in spinally injured patients. J Hosp Infect 1990b;15(3):235-243.

Sanderson PJ, Weissler S. The relation of colonization of the perineum to bacteriuria and environmental contamination in spinally injured patients. J Hosp Infect 1990a;15(3):229-234.

Sandock DS, Gothe BG, Bodner DR. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Paraplegia 1995;33(3):156-160.

Sapico FL, Lindquist LB, Montgomerie JZ, Jimenez EM, Morrow JW. Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose. Urology 1980;15(5):457-460.

Sarica S, Akkoc Y, Karapolat H, Aktug H. Comparison of the use of conventional, hydrophilic and gel-lubricated catheters with regard to urethral micro trauma, urinary system infection, and patient satisfaction in patients with spinal cord injury: A randomized controlled study. Eur J Phys Rehabil Med 2010;46:473-480.

Schlager TA, Ashe K, Hendley JO. Effect of a phosphate supplement on urine pH in patients with neurogenic bladder receiving intermittent catheterization. Spinal Cord 2005;43(3):187-189.

Schurch B, de SM, Denys P, Chartier-Kastler E, Haab F, Everaert K et al. Botulinum toxin type is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005;174(1):196-200.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron R. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence. Arch Phys Med Rehabil 2007;88(5):646-652.

Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 1996;155(3):1023-1029.

Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164(3 Pt 1):692-697.

Seoane-Rodriguez S, Sanchez R-L, Montoto-Marques A, Salvador-de la BS, Ferreiro-Velasco ME, varez-Castelo L et al. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia. Spinal Cord 2007;45(9):621-626.

Shah PS, Cannon JP, Sullivan CL, Nemchausky B, Pachucki CT. Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling catheters. Am J Health Syst Pharm 2005;62(1):74-77.

Sheriff MK, Foley S, McFarlane J, Nauth-Misir R, Craggs M, Shah PJ. Long-term suprapubic catheterisation: Clinical outcome and satisfaction survey. Spinal Cord 1998;36(3):171-176. Shin JC, Kim YW, Park CI, Kang SW, Yang SC. Effect of the intravesical resiniferatoxin instillation evaluated by the ice provocative urodynamic study. Spinal Cord 2006;44(5):309-314.

Shin JC, Park C, Kim HJ, Lee IY. Significance of low compliance bladder in cauda equine injury. Spinal Cord 2002;40:650-655. Shohl AT, Janney JH. Optimal growth of E.coli in urine at varying hydrogen ion concentrations. J Urol 1917;1:211-228.

Sievert KD, Amend B, Gakis G, Toomey P, Badke A, Kaps HP, Stenzl A. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010;67:74-84.

Silva C, Silva J, Ribeiro MJ, Avelino A, Cruz F. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial. Eur Urol 2005;48(4):650-655.

Singh G, Thomas DG. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators. Neurourol Urodyn 1995;14(1):65-71.

Spinelli M, Malaguti S, Giardiello G, Lazzeri M, Tarantola J, Van Den Hombergh U. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: Description of the method and preliminary data. Neurology and Urodynamics 2005;24:305-309.

Spinu A, Onose G, Daia C, Pantu C, Anghelescu A, Onose L, Mihaescu A. Intermittent catheterization in the management of post spinal cord injury (SCI) neurogenic bladder using new hydrophilic, with lubrication in close circuit devices-our preliminary results. Journal of Medicine and Life 2012;5(1):21-28.

Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329(18):1328-1334. Steers WD, Meythaler JM, Haworth C, Herrell D, Park TS. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 1992;148(6):1849-1855.

Stohrer M, Bauer P, Giannetti BM, Richter R, Burgdorfer H, Murtz G. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial. Urol Int 1991;47(3):138-143.

Stohrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia–a double-blind, placebo-controlled clinical trial. Spinal Cord 1999;37(3):196-200.

Stohrer M, Murtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele J.J. and the Propiverine Investigator Group. Propiverine compared to Oxybutynin in neurogenic detrusor overactivity – results of a randomized, double-blind, multicenter clinical study. European Urology 2007;51:235–242.

Stöhrer M, Mürtz G, Kramer G, Warnack W, Primus G, Jinga V et al.Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Spinal cord 2013;51(5):419-423.

Sugimura T, Arnold E, English S, Moore J. Chronic suprapubic catheterization in the management of patients with spinal cord injuries: Analysis of upper and lower urinary tract complications. BJU International 2008, 101, 1396-1400.

Sutherland RS, Kogan BA, Baskin LS, Mevorach RA. Clean intermittent catheterization in boys using the LoFric catheter. J Urol 1996;156(6):2041-2043.

Sylora JA, Gonzalez R, Vaughn M, Reinberg Y. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. J Urol 1997;157(1):48-50.

Szollar SM, Lee SM. Intravesical oxybutynin for spinal cord injury patients. Spinal cord 1996;34(5):284-287.

Taie K, Moombeini H, Khazaeli D, Salari Panah firouzabadi M. Improvement of urodynamic indicies by single dose oral tadalafil in men with supra sacral spinal cord injury. Urology 2010;7(4):249-253.

Tanagho EA, Schmidt RA. Bladder pacemaker: Scientific basis and clinical future. Urology 1982 20:614–619.

Tantisiriwat N, Kittisomprayoonkul W, Sukonthamarn K, Unhasuta C, Suankratay C, Tantisiriwat W et al. Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005. J Med Assoc Thai 2007;90(11):2482-2486.

Tow AM, Toh KL, Chan SP, Consigliere D. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore. Ann Acad Med Singapore 2007;36(1):11-17.

Trautner BW, Darouiche RO. Prevention of urinary tract infection in patients with spinal cord injury. J Spinal Cord Med 2002;25(4):277-283.

Trautner BW, Hull RA, Thornby JL, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control hosp Epidemiol 2007;28(1):92-94.

Tsai SJ, Ying TH, Huang YH, Cheng JW, Bih LI, Lew HL. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: Localization with combined fluoroscopic and electromyographic guidance. Arch Phys Med Rehabil 2009;90:832-836.

Vaidyananthan S, Soni BM, Brown E, Sett P, Krishnan KR, Bingley J et al. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction. Spinal Cord 1998;36(6):409-414.

Van Kerrebroeck EV, van der Aa HE, Bosch JL, Koldewijn EL, Vorsteveld JH, Debruyne FM. Sacral rhizotomies and electrical bladder stimulation in spinal cord injury. Part I: Clinical and urodynamic analysis. Dutch Study Group on Sacral Anterior Root Stimulation. Eur Urol 1997;31(3):263-271.

Van Kerrebroeck PE, Koldewijn EL, Rosier PF, Wijkstra H, Debruyne FM. Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. J Urol 1996;155(4):1378-1381.

Vapneck JM, Maynard FM, Kim J. A prospective randomized trial of the LoFric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization. J Urol 2003;169(3):994-998.

Vastenholt JM, Snoek GJ, Buschman HPJ, van der Aa HE, Alleman ERJ, IJzerman MJ. A 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: Quality of life and users’ experiences. Spinal Cord 2003;41(7):397-402.

Vickrey BG, Shekelle P, Morton S, Clark K, Pathak M, Kamberg C. Prevention and management of urinary tract infections in paralyzed persons. Evid Rep Technol Assess (Summ) 1999;(6):1-3.

Vodusek DB, Light K, Libby JM. Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurology and Urodynamics 2005;5(4):381-389. Waites KB, Canupp KC, Armstrong S, DeVivo MJ. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spinal Cord Med 2004;27(1):35-40.

Waites KB, Canupp KC, DeVivo MJ. Efficacy and tolerance of norfloxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury. Urology 1991;38(6):589-596.

Waites KB, Canupp KC, Roper JF, Camp SM, Chen Y. Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. J Spinal Cord Med 2006;29(3):217-226.

Waller L, Jonsson O, Norlen L, Sullivan L. Clean intermittent catheterization in spinal cord injury patients: Long-term followup of a hydrophilic low friction technique. J Urology 1995;153:345-348.

Waller L, Telander M, Sullivan L. The importance of osmolality in hydrophilic urethral catheters: A crossover study. Spinal Cord 1997;35(4):229-233.

Watanabe T, Yokoyama T, Sasaki K, Nozaki K, Ozawa H, Kumon H. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity. International J Urol 2004;11(4):200-205.

Wefer B, Ehlken B, Bremer J, Burgdörfer H, Domurath B, Hampel C. Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany. World J Urol 2010;28(3):385-390.

Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol 2000;163(3):768-772.

Wheeler JS Jr, Walter JS, Sibley P. Management of incontinent SCI patients with penile stimulation: Preliminary results. J Am Paraplegia Soc 1994;17(2):55-59.

Wheeler JS Jr, Walter JS, Zaszczurynski PJ. Bladder inhibition by penile nerve stimulation in spinal cord injury patients. J Urol 1992;147(1):100-103.

Wheeler JS Jr., Robinson CJ, Culkin DJ, Bolan JM. The effect of thigh muscle reconditioning by electrical stimulation on urodynamic activity in SCI patients. J Am Paraplegia Soc 1986;9(1-2):16-23.

Woodbury MG, Hayes KC, Askes HK. Intermittent catheterization practices following spinal cord injury: A national survey. Can J Urol 2008;15(3):4065-4071.

Wyndaele J, Van Kerrebroeck P. The effects of 4 weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study. Spinal Cord 1995;33(11):625-627.

Wyndaele JJ, De Ridder D, Everaert K, Heilporn A, Congard-Chassol B. Evaluation of the use of Urocath-Gel catheters for intermittent self-catheterization by male patients using conventional catheters for a long time. Spinal Cord 2000;38:97-99.

Wyndaele JJ, De Sy WA, Claessens H. Evaluation of different methods of bladder drainage used in the early care of spinal cord injury patients. Paraplegia 1985;23:18-26. Wyndaele JJ, De Taeye N. Early intermittent self-catheterisation after spinal cord injury. Paraplegia 1990;28(2):76-80.

Wyndaele JJ, Madersbacher H, Kovindha A. Conservative treatment of the neuropathic bladder in spinal cord injured patients. Spinal Cord 2001;39(6):294-300.

Wyndaele JJ. Conservative treatment of patients with neurogenic bladder. European Urology Supplements 2008;7(8):557-565.

Xiao CH, Du MX, Dai C, Li B, Nitti VW, de Groat WC. Aan artificial somatic central nervous system autonomic reflex pathway for controllable micturition afer spinal cord injury: Preliminary results in 15 patients. J Urol 2003;170:1237-1241.

Yadav A, Vaidyanathan S, Panigrahi D. Clean intermittent catheterisation for the neuropathic bladder. Paraplegia 1993;31(6):380-383. Yang CC, Clowers DE. Screening cystoscopy in chronically catheterized spinal cord injury patients. Spinal Cord. 1999;37(3):204207.

Yavuzer G, Gok H, Tuncer S, Soygur T, Arikan N, Arasil T. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38(12):762-765.

Yoo PB, Horvath EE, Amundsen CL, Webster GD, Grill WM. Intraurethral activation of excitatory bladder reflexes in persons with spinal cord injury. Conf Proc IEEE Eng Med Biol Soc 2009:6781-6784.

Zahariou A, Karagiannis G, Papaioannou P, Stathi K, Michail X. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury. Eura Medicophys 2007;43(3):333-338.

Zommick JN, Simoneau AR, Skinner DG, Ginsberg DA. Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urology 2003;169(6):2184-2187.